Skip to content

Category: Drug availability

Explore our medication guides and pharmacology articles within this category.

Is clozapine still available? Navigating new access and monitoring guidelines

4 min read
In a landmark decision in June 2025, the U.S. Food and Drug Administration (FDA) officially eliminated the Clozapine Risk Evaluation and Mitigation Strategy (REMS) program, which had long governed its distribution. This major regulatory update directly answers the question, **is clozapine still available?**, by confirming its continued availability with substantially improved access for patients and clinicians.

Is tirzepatide shortage removed? What Patients and Providers Need to Know

4 min read
The U.S. Food and Drug Administration (FDA) officially determined that the shortage of tirzepatide injections was resolved in December 2024, after nearly two years of supply issues due to overwhelming demand. This definitive end to the **tirzepatide shortage** carries significant implications for patients, providers, and the compounding pharmacy industry.

When Can You No Longer Get Tirzepatide? Understanding FDA Rulings and Availability

5 min read
Following the official resolution of the tirzepatide drug shortage by the U.S. Food and Drug Administration (FDA) in December 2024, compounding pharmacies were required to cease mass production of compounded versions. This means patients who were relying on these alternatives could no longer get Tirzepatide from these sources after specific regulatory deadlines passed.